Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
CCO Oncology Podcast
Claim This Podcastby Decera Clinical Education
4.5(2 reviews)
256 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
55
Podcast Authority
BetaFairBased on show quality, social media presence, reviews, charts, and more
Quality76
Social0
YouTube0
Engagement85
Podcast Overview
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Language
🇺🇲
Publishing Since
8/10/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
55
Podcast Authority
BetaFairBased on show quality, social media presence, reviews, charts, and more
Quality76
Social0
YouTube0
Engagement85
7
Excellent Areas
2
Good Performance
10
Growth Opportunities
excellent
Episode Length
20 minutes
Performing excellently!
good
Publishing Consistency
Every 9 days
Recommendations available
Unlock the full report to see detailed tips
poor
Episode Thumbnails
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for CCO Oncology Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 23, 2026
Optimizing Bispecific Antibody Safety and Care Coordination From the Pharmacy in RRMM
Bispecific antibody therapy continues to rapidly change the care of patients with relapsed/refractory multiple myeloma (RRMM). In this podcast, learners will hear 2 oncology specialty pharmacists discuss recent evidence-based information and updated safe-use guidelines and implementation of bispecific antibodies incorporated into RRMM management. They will describe the major toxicities associated with bispecific antibodies targeting BCMA and GPRC5, including CRS, ICANS, and infection; how they work within their institutions to reduce the risk of these adverse events from occurring; and their experience with monitoring for and treating these adverse events when they arise.
July 22, 2026
Targeting the Future of Pancreatic Cancer Care: RAS, Biomarkers, and Emerging Therapies
With updates from the 2026 ASCO Annual Conference signaling long-awaited progress in pancreatic cancer, expert faculty review and discuss recent advances that may influence therapeutic decision-making in a historically chemotherapy-centered field. They examine the current role and limitations of multiagent chemotherapy, the growing importance of early germline and somatic testing, and emerging data for RAS-targeted therapies, including pan-RAS inhibition and allele-specific approaches. Faculty also discuss how molecular subsets such as KRAS wild-type disease, NRG1 fusions, CLDN18.2 expression, MTAP loss, and other actionable alterations may shape future treatment selection, sequencing, clinical trial enrollment, and supportive care planning for patients with pancreatic cancer.
July 14, 2026
Beyond BCMA: How GPRC5D-Targeted Therapy Fits Iinto Multiple Myeloma Care Today
Targeted therapies are becoming more common treatment options for patients with multiple myeloma. Specifically, there have been emerging clinical data on GPRC5D-directed bispecific antibodies for patients with relapsed and refractory disease. In this podcast, 2 experts in the field discuss how they are using GPRC5D-directed therapies in their practice, including treatment planning, patient selection, adverse event management, and how new combination strategies may affect practice.
256 total episodes available
Recent guests on CCO Oncology Podcast
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Sara A Hurvitz
Guest
La-Urshalar B Brock
Guest
Jordan Hill
Guest
Similar Podcasts
Discover related shows you might enjoy
Two Onc Docs
Sam and Karine
ASCO Daily News
American Society of Clinical Oncology (ASCO)
Oncology Today with Dr Neil Love
Dr. Neil Love
OncLive® On Air
OncLive® On Air
Oncology Brothers
Oncology Brothers
ASCO Guidelines
American Society of Clinical Oncology (ASCO)
Research To Practice | Oncology Videos
Dr Neil Love
Nature Podcast
Springer Nature Limited
Hematologic Oncology Update
Dr. Neil Love
OncoPharm
John Bossaer
BioCentury This Week
BioCentury
WolverHeme Happy Hour
Bernard Marini, Anthony Perissinotti, et al.
Gastrointestinal Cancer Update
Dr. Neil Love
HemeTalks: Conversations in Hematology Education
American Society of Hematology
Lung Cancer Considered
IASLC
Deep-dive analytics for CCO Oncology Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is CCO Oncology Podcast?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.